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Intercellular adhesion plays a role in cancer formation and protein has a key potential in maintaining cell adhesion, 
including syndecan-1. Meanwhile, oral cancer originates from the oral epithelium, which has an invasive and metastatic 
level. Its treatments involving chemotherapy and radiotherapy commonly leave unfavorable side effects, hence, suitable 
alternatives are needed. Natural ingredients are widely used as an alternative treatment for cancer, for example, Ganoderma 
lucidum (G. lucidum) which has anti-cancer and anti-angiogenic properties, induces apoptosis, stimulates an immune 
response, inhibits the degradation of Extracellular matrix (ECM), reduces inflammation, affects cell cycles, cytotoxic, and 
acts as an antioxidant.This study aims to determine the effect of ethanol extract from Ganoderma lucidum Cianjur isolate 
on syndecan-1 expression in KB CCL-17 oral cell cancer. This was an experimental study with a post-test only control 
group design, the treatment group used G. lucidum ethanol extract with a concentration of 2.12 μg/ml (P1), 4.24 μg/ml 
(P2), and 8.49 μg/ml (P3), while the positive control group used cisplatin with a concentration of 11.5 μg/ml (K1). In 
contrast, the negative control used aquadest (K0), while syndecan-1 expression was observed using the 
immunohistochemical examination.The highest syndecan-1 expansion rate was found in the treatment group with a 
concentration of 8.49 μg/ml. A significant difference was indicated by one-way ANOVA (p<0.05) between K0 - K1, K0 
- P1, K0 - P2, K0 - P3, K1 - P1, K1 - P2, K1 - P3, P1 - P2, as well as P1 and P3. The administration of ethanol extract from 
G. lucidum Cianjur isolate increases syndecan-1 expression in KB CCL-17 oral cell cancer. 
 




Adhesi sel antar sel memainkan peran terhadap pembentukan kanker. Protein yang berperan dalam mempertahankan 
adhesi sel adalah Syndecan-1. Kanker rongga mulut berasal dari epitel rongga mulut yang memiliki tingkat invasif dan 
metastasis. Perawatan kanker yang mengalami invasif dan metastasis dilakukan perawatan kemoterapi dan radioterapi, 
namun efek dari perawatan tersebut memiliki efek samping yang tidak menguntungkan, untuk itu dibutuhkan perawatan 
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alternatif. Pengobatan menggunakan bahan alam mulai digunakan sebagai alternatif perawatan kanker. Salah satu bahan 
alam sebagai anti kanker adalah Ganoderma lucidum(G.lucidum) yang memiliki kemampuan anti angiogeneis, 
menginduksi apoptosis, menstimulasi respon imunitas, menghambat degradasi Ekstracelullar matrix (ECM), mengurangi 
inflamasi, mempengaruhi siklus sel, kemampuan sitotoksis dan sebagai antioksidan. Mengetahui ekspresi syndecan-1 yang 
diberikan ekstrak etanol Ganoderma lucidum isolat Cianjur pada kultur sel rongga mulut KB CCL-17.Desaign penelitian 
yang digunakan adalah post-test only with control group design. Kelompok perlakuan menggunakan ekstrak etanol 
G.lucidum dengan konsentrasi 2,12 µg/ml (P1), 4,24 µg/ml(P2) dan 8,49 µg/ml (P3). Kelompok kontrol positif 
menggunakan Cisplatin dengan konsentrasi 11, 5 µg/ml(K1) dan Kelompok kontrol negatif menggunakan aquabidest 
(K0). Ekspresi syndecan-1 diamati dengan pemeriksaan imunohistokimia.Rerata ekspesi syndecan-1 tertinggi pada 
kelompok perlakuan dengan konsentrasi ekstrak etanol G.lucidum konsentrasi 8,49 µg/ml. Perbedaan signifikan 
ditunjukan menggunakan analisis one way ANOVA (p<0,05) antara K0 dengan K1, K0 dengan P1, K0 dengan P2, K0 
dengan P3, K1 dengan P2, K1 dengan P2, K1 dengan P3, P1 dengan P2 dan P1 dengan P3. Terdapat peningkatan jumlah 
pada ekspresi syndecan-1 yang diberikan ekstrak etanol G.lucidum isolat Cianjur pada kultur sel rongga mulut (KB CCL-
17) 
 







Oral cancer had an incidence of 354,864 cases in 
2018, with a mortality rate of 177,384.1 The in-
creased incidence is influenced by poor prognosis, 
low survival rates, and poor radiotherapy treatment.2 
Besides, cancer has an invasive and metastatic abi-
lity, which accounts for 90% of the deaths. Protein 
and gene expression are used to predict the inva-
siveness and metastasis, hence, they are used as a 
reference in determining tumor prognosis 3. 
Syndecan-1 is commonly applied as a diagnostic 
standard biomarker by analyzing the number of ex-
pressions which often decrease due to the down re-
gulation mechanism of cancer 4. Cancers with a dec-
reased expression of syndecan-1 are commonly 
found in the lungs, kidneys, as well as head and 
neck.5 
Cancer treatment uses surgical therapy combined 
with radiotherapy and/or chemotherapy, but these 
treatments have side effects on the patients.5, 7 There-
fore, suitable and safe alternatives such as natural in-
gredients are needed to minimize the side effects. 
Ganoderma lucidum (G. lucidum) is a fungus that is 
cytotoxic, has anti-cancer properties by inducing 
apoptosis, suppressing invasive cancer cells, regu-
lating key signaling molecules, 8 inhibiting progres-
sive cell cycles, and suppressing angiogenesis.8, 9. 
Studies on the effect of G. lucidum Cianjur ethanol 
extract and Syndecan-1 expression on KB CCL-17 
oral cancer cell has not been conducted. Therefore, 
this study aims to determine the potential of this 






MATERIALS AND METHODS 
 
This study used a post-test group-only design with 
a purely experimental approach. The treatment group 
was given G. lucidum ethanol extract with a 
concentration of 2.12, 4.24, and 8.49 µg/ml, while the 
positive control group was treated using cisplatin at a 
concentration of 11.5 μg/ml and the negative control 
was administered with aquadest. Each treat-ment and 
control was repeated four times, while the G. lucidum 
fungus used in the study was obtained from the CV 
Asa Agro Corporation. It was har-vested after four 
months of planting, and three months after the fruit 
body sprung out. The fungus lives in the lowlands 
with a temperature of 30°C, humidity of 
approximately 80%, and a pH of 7. It was collected 
in September 2019 and the part used was 300 grams 
thinly sliced fruiting body, which were placed into an 
oven of 70°C for 2 hours for drying. The extract 
method used was maceration with 96% ethanol 
solvent. The ratio of solvent to powder was 5:5 with 
1,500 ml of ethanol containing 300 grams of powder. 
The mixture was stirred and tightly closed with 
aluminum foil, left for 3x24 hours by stirring, and 
filtered every day. 
KB CCL-17 cancer cells obtained from ATCC 
with epithelial morphology were taken from liquid 
nitrogen tanks and then diluted with water baths at 
37°C. The cells were inserted into centrifuge tubes 
containing 10 mL DMEM-serum medium and cen-
trifuged within 10 minutes at 1200 rpm. The super-
natant was separated between sediment and liquid, 
while the precipitate formed along with DMEM, was 
kept for 20 minutes, then the centrifuge was 
performed at 1200 rpm for 10 minutes. Further-more, 
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the next suspension was placed into Tissue Culture 
Flask (TCF) with a growth medium containing 20% 
FBS and then viewed under an in-verted microscope. 
Living cells appeared round, glowing, and clear. The 
TCF was incubated in an incubator at 37°C and 5% 
CO2 with a non-tense lid, while the cells were given 
treatment when 80% con-fluent occurred, which was 
marked with a yello-wing medium. Moreover, the 
cells were treated with the extracts and incubated for 
24 hours on a 24 well microplate. They were further 
washed with 500 µL Phosphate buffer saline (PBS), 
7% ethanol and 3% hydrogen peroxide at 100 µL, 
and kept for 10 minutes. The solution was then 
discarded with a micropipette, and the coverslip was 
washed with 500 µL PBS. PBS was taken with a 1 
mL micro-pipette and transferred to a glass 
preparation. Pre-diluted blocking serum of 100 µL 
was dropped and kept for 10 minutes, then, an 
immunohistochemistry examination was performed 
to observe syndecan-1 expressions. 
Subsequently, data were tabulated and tested for 
normality by Shapiro-Wilk, then, the analysis was 
performed using the one-way ANOVA test. When 
the data is normally distributed with a confidence 
level of 95% (p <0.05), a post-hoc Least Signi-
ficance Difference (LSD) test was performed to 
determine the presence of significant differences 




Immunohistochemical observations were per-
formed on 10 random Microscope fields of view with 
a magnification of 400 times. The results showed po-
sitive brown Syndecan-1 on cytoplasm and negative 
with no staining. The syndecan-1 ex-pression on 
immunohistochemical examination is shown in 
Figure 1. 
The analysis results of Syndecan-1 expression in 
oral cancer KB CCL-17 culture are shown in Table 
1, shows the mean of syndecan-1 expression in the 
KB CCL-17 oral cancer cell culture from each group. 
Syndecan-1 expression was mostly observed in the 
treatment group at a concentration of 8.49 μg/ml, 
with a mean of 34.59%. In contrast, the smallest 
expression was found in the non-treatment group 
with a mean of 1.51%. Based on the results, the mean 
of syndecan-1 expression in the oral cancer cell 
culture with ethanol extract increased proportionally 
with the increasing concentration. 
After the mean was obtained, statistic tests were 
performed, including normality test using Shapiro-
Wilk and homogeneity using the Levene test, then 
the one-way ANOVA was used to analyze the data. 
The normality test showed a significance value of 
0.125, while Shapiro-Wilk results showed that the 
data were normally distributed with p>0.05. Fur-
thermore, the homogeneity test obtained a signi-
ficance value of 0.233 after the data were trans-
formed. A value of p>0.05 indicates homogeneity, 
hence, the data were used. 
The one-way ANOVA parametric statistical test 
requires that data have normal distribution and ho-
mogeneity. It was used to analyze differences in 
syndecan-1 expression between groups and treat-
ments. Table 2 depicts the test results. 
Based on the results, the expression of syndecan-1 
in oral cancer cell KB-CCL-17 cultures between the 
non-treatment group, as well as others treated with 
cisplatin, and G.lucidum ethanol extract of 2.12 
μg/ml, 4.24 μg/ml and 8.49 μg/ml had significant 
differences with a value of 0.000 (p<0.05). Further-
more, there was a significant difference in the one-
way ANOVA parametric test, while the LSD test 
was conducted to identify significant differences 
between the groups. Table 3 depicts the LSD pa-
rametric test results. 
The LSD parametric test results in Table 3 showed 
that there were differences in the expression of syn-
decan-1 between each group, except the P2 and P3 
groups. The difference was categorized as signi-
ficant when the p-value is <0.05. The significance 




Based on the results, there were differences 
between the groups without treatment, as well as 
cisplatin, G. lucidum ethanol extract at 2.12 μg/ml 
(P1), 4.24 μg/ml (P2), and 8.49 μg/ml (P3). Further 
tests using LSD showed that there were significant 
differences in the expression of syndecan-1 between 
the non-treatment, cisplatin, and treatment groups of 
P1, P2, P3. Ethanol extract of G. lucidum increased 
the syndecan-1 expression in oral cancer cell KB 
CCL-17. Meanwhile, the expression is related to cell 
growth regulation, pro-liferation, the interaction 
between heparin and growth factor groups, angio-
genesis induction, growth promotion, tumor pro-
gression, and contributes directly to invasive and 
metastatic abilities in malignant tumors 10. 
A correlation between metastases in invasive 
ductal carcinoma and the number of syndecan-1 ex-
pressions in primary tumors was found in previous 
studies. This occurred because syndecan-1 is ex-
pressed in more than 90% of epithelium tumors. The 
high expression is related to the maintenance of 
epithelial cell morphology and increasing the in-
teraction of cell adhesion with matrix components. 
Aside from maintaining cell adhesion as a physio-
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logical function, syndecan-1 also regulates patholo-
gical processes, such as invasive tumor cells, angio-
genesis, and metastasis10,11  
Based on the above data, the lowest mean of syn-
decan-1 expression was found in the group without 
treatment. This is because the expression is reduced 
in epithelial tumors in relation to the prognosis as 
well as due to an increase in MMP-9 which has op-
posite effects with syndecan-1, hence, a decrease in 
MMP-9 expression increases the syndecan-1 ex-
pression13  
Syndecan-1 expression in ameloblastoma shows 
that Desmoplastic Ameloblastoma has a smaller 
number compared to other types.14 Multicystic types 
which have invasive properties from weak to strong 
are follicular, akantomatos, granular, plexiform, and 
desmoplastic types, respectively.16 Furthermore, in 
odontogenic keratocyst, unicystic ameloblastoma, 
and dentigerous cyst, low syndecan-1 expression in-
creases the invasive and destructive ability of neo-
plastic cells in unicystic ameloblastoma and extends 
to surrounding tissues.16 The mean of expression in 
epithelial tissues with ameloblastoma showed a de-
crease of 26.3%, keratocystic odontogenic tumor 
(KCOT) 92.3%, and dentigerous cyst 100%. There 
was an association with cell differentiation and 
invasive ability into deeper tissues on malignancy. Al 
Otaibi, et al. found that the mean of syndecan-1 
expression in normal cells was more than mild, 
moderate, and severe dysplasia in the oral cancer cell, 
but there was no significant difference between 
tumor grades.15, 18 
Syndecan-1 also increases in human fibrosarcoma 
cell line HT-1080. It stimulates malignancy by in-
creasing proliferation, metastatic potential, and mi-
gration ability. Overexpression of the branch by-
passes the ectodomain, but it has amino acids in the 
juxta-membrane that promote proliferation and 
chmotaxis. The ectodomain increases tumor cell 
proliferation by the migratory ability of syndecan-1, 
which is enhanced by syndecan-2. Increased syn-
decan-1 expression triggers IGF1R activation and 
elevates Ets-1 proliferation. Moreover, syndecan-2 
transfection with an upregulated mechanism increa-
ses the chemotaxis migration of HT-1080 cells to the 
ECM protein. The proliferation of HT-1080 cells 
occurs due to hyper-phosphorylation of Rb (re-
tinoblastoma) by the CDK2 (cyclin-dependent 
kinase 2) -cyclin E1 complex. This process is also 
stimulated by syndecan-1, hence, increasing its ex-
pression also raises syndecan-2. 17, 18 
Increased expression of syndecan-1 reduces the 
ability of cell proliferation by prolonging G1 and S 
phases in the cell cycle and retarded migration. The 
results show that syndecan-1 work simultaneously in 
inhibiting the motility and cycle of mesenchymal 
cells that are not present in the ectodomain, hence, it 
has a dual role. 17 
There was no significant difference in the mean of 
syndecan-1 expression in the P2 and P3 treatment 
groups. In other words, G. lucidum ethanol extract of 
4.24 μg/ml and 8.49 μg/ml had a comparable abi-lity 
to increase syndecan-1 expression. Based on the LSD 
parametric test, there was a significant difference in 
the expression between P1 and P3 groups, as well as 
between P2 and P3 groups. These results showed that 
the ethanol extract with a concentration of 4.24 μg/ml 
and 8.49 μg/ml was stronger against the increased 
syndecan-1 expression compared to 2.12 μg/ml. 
The treatment groups, as well as negative and po-
sitive controls, had syndecan-1 below the normal 
value which is greater than 66%.19 Moreover, there 
was a significant difference in the syndecan-1 ex-
pression in the K1 group (cisplatin) with P2 as well 
as the K1 Group with P3. These results indicate that 
the effectiveness of G. lucidum ethanol extract was 
higher than cisplatin as a chemotherapy agent. 
Decreased expression of more than 80% of oral 
cancer is a risk factor for recurrence and death after 
24 months of surgery, hence, syndecan-1 in the stro-
ma is a reliable indicator of oral cancer prognosis. 
The increased expression associated with cytotoxic 
treatment shows clear predictive factors and a good 
prognosis in oral cancer.20 Furthermore, the loss of 
syndecan-1 in breast cancer causes reduced metas-
tasis in the brain, therefore, when the expression 
increases, the potential risk of metastasis to the brain 
is elevated. Also, the loss of syndecan-1 triggers 
changes in breast cancer cells to secrete cyto-
kines/chemokines that affect BBB (Blood-brain 
barrier). The cytokines / chemokines regulated by 
syndecan-1 are IL-8, IL-6, and IL-34. Altogether, 
they influence the integrity and transmigration of 
BBB mediated by CCL5, ICAM-1, IL-6, IL-8, and 
GM-CSF. The syndecan-1 expression on fibroblast 
stroma and endothelial cells enhances growth, an-
giogenesis, and forms a microenvironment that fa-
vors invasive breast cancer 21. Syndecan-1 expres-
sion in fibroblast stroma is needed to perform me-
tastasis in 4T1 breast cancer mice. 22 
Nevertheless, the expression by some cancers is 
not always a risk factor for increasing metastasis to 
the brain. Prostate cancer characterized by an increa-
sed syndecan-1 expression has a low incidence of 
metastasis to the brain namely 0.2-2%. The syn-
decan-1 expression also increases in lung cancer, but 
the presence of a correlation with a good or poor 
prognosis is unclear. 23 
These results indicate that the ethanol extract of G. 
Lucidum effectively increases the number of syn-
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decan-1 expressions, therefore, G. Lucidum needs to 
be developed as a potential anti-cancer agent to sup-
press the invasive and metastatic levels of oral can-
cer. In conclusion, the administration of ethanol ex-
tract from G. lucidum Cianjur isolate increases syn-
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Table1. Analysis Results of Syndecan-1 Expression in oral cancer cell KB CCL-17 Culture. 
 
No Group Mean (%)± SD 
1 Without Treatment  1.51 ± 0.52 
2 Cisplatin 11.5 μg/ml  25.53 ± 2.45 
3 Ethanol Extract of G.lucidum– Concentration 
of 2.12  μg/ml 
10.77 ± 1.33 
4 Ethanol Extract of G.lucidum– Concentration 
of 4.24 μg/ml 
32.29  ± 6.05 
5 Ethanol Extract of G.lucidum– Concentration 
of 8.49 μg/ml 
 34.59 ± 1.66 
Source: Primary data was processed, 2020 
 
 
Table2. One-way ANOVA test on Syndecan-1 Expression 
 
 Sum of squares df Mean squares F Sig. 
Between 
Groups  
2048.128 4 512.032 48.641 .000 
Within Groups 94.741 9 10.527   
Total 2142.869 13    
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Table3. Results of LSD Parametric Tests between Groups on Syndecan-1 Expressions 
 
No. Group K0 K1 P1 P2 P3 










































Description:  *  = signficant (p<0.05) 
  ** = very significant (p<0.01) 
  K0 = negative control (without treatment)  
  K1 = positive control (cisplatin 11.35 μg/ml) 
  P1 = ethanol extract of G.lucidum with concentration of 2.12 μg/ml 
  P2 = ethanol extract of G.lucidum with concentration of 4.24 μg/ml 
  P3 = ethanol extract of G.lucidum with concentration of 8.49 μg/ml 







Figure 1. Expression of Syndecan-1 with A. treatment ethanol extract; B. Cisplatin; C. Aquades on immunohistochemical 
examination 
 : cells that did not express syndecan-1 
 : cells that expressed syndecan-1  
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